Literature DB >> 25413923

Severity markers in severe leptospirosis: a cohort study.

M Mikulski1, P Boisier, F Lacassin, M-E Soupé-Gilbert, C Mauron, L Bruyere-Ostells, D Bonte, Y Barguil, A-C Gourinat, M Matsui, F Vernel-Pauillac, C Goarant.   

Abstract

We aimed to evaluate parameters for their value as severity markers in hospitalized leptospirosis patients. We recruited 47 informed adult consenting patients and assessed a number of clinical, hematological, biochemical, and biological variables. Patients were sorted according to severity based on fatality or the requirement of mechanical ventilation or dialysis; the parameters studied were compared between groups on inclusion and the next day. Beside septic shock presentation or a high severity score (Simplified Acute Physiology Score; SAPS II), increased lactate, total bilirubin, lipase, and AST/ALT ratio or a decreased cytokines IL-10/TNF-α ratio were all significantly associated with severity. The gene expression of the IL-1 receptor antagonist IL-1ra, IL-1α, and the long pentraxin PTX-3 were also transcribed at higher levels in most severe cases. Patients could rapidly improve or deteriorate, highlighting the need for a new assessment the next day. Our results add to the limited body of knowledge about severity markers in leptospirosis. They also suggest that patients should be reassessed the next day before being possibly discharged from the hospital. Further studies are needed in order to confirm relevant and reliable prognostic parameters in leptospirosis that would be helpful for the purpose of triage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25413923     DOI: 10.1007/s10096-014-2275-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  47 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 2.  The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review.

Authors:  J S Friedland; D A Warrell
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

3.  Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease.

Authors:  C Goarant; S Laumond-Barny; J Perez; F Vernel-Pauillac; S Chanteau; A Guigon
Journal:  Trop Med Int Health       Date:  2009-06-22       Impact factor: 2.622

4.  Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis.

Authors:  H Tajiki; R Salomão
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

5.  The ratio of plasma levels of IL-10/TNF-alpha and its relationship to disease severity and survival in patients with leptospirosis.

Authors: 
Journal:  Braz J Infect Dis       Date:  1997-06       Impact factor: 1.949

6.  Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand.

Authors:  Thanachai Panaphut; Somnuek Domrongkitchaiporn; Bandit Thinkamrop
Journal:  Int J Infect Dis       Date:  2002-03       Impact factor: 3.623

7.  Pulmonary involvement in leptospirosis.

Authors:  M A Martínez García; A de Diego Damiá; R Menéndez Villanueva; J L López Hontagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-06       Impact factor: 3.267

8.  Leptospirosis in Franche-Comté (FRANCE): clinical, biological, and therapeutic data.

Authors:  J M Estavoyer; C Chirouze; J F Faucher; N Floret; G Couetdic; J Leroy; B Hoen
Journal:  Med Mal Infect       Date:  2013-07-30       Impact factor: 2.152

Review 9.  The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.

Authors:  Gilles Guerrier; Eric D'Ortenzio
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.

Authors:  Eliana A G Reis; José E Hagan; Guilherme S Ribeiro; Andrea Teixeira-Carvalho; Olindo A Martins-Filho; Ruth R Montgomery; Albert C Shaw; Albert I Ko; Mitermayer G Reis
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more
  10 in total

1.  Elevated levels of IL-8 in fatal leptospirosis.

Authors:  Wan Shahriman Yushdie Wan Yusoff; Maha Abdullah; Zamberi Sekawi; Fairuz Amran; Muhammad Yazli Yuhana; Niazlin Mohd Taib; Anim Md Shah; Syafinaz Amin Nordin
Journal:  Pathog Glob Health       Date:  2020-02-05       Impact factor: 2.894

Review 2.  Molecular diagnostics for human leptospirosis.

Authors:  Jesse J Waggoner; Benjamin A Pinsky
Journal:  Curr Opin Infect Dis       Date:  2016-10       Impact factor: 4.915

3.  Pulmonary haemorrhage as the earliest sign of severe leptospirosis in hamster model challenged with Leptospira interrogans strain HP358.

Authors:  Noraini Philip; Sivan Padma Priya; Ahmad Hussein Jumah Badawi; Mohd Hafidz Mohd Izhar; Norhafizah Mohtarrudin; Tengku Azmi Tengku Ibrahim; Zamberi Sekawi; Vasantha Kumari Neela
Journal:  PLoS Negl Trop Dis       Date:  2022-05-18

4.  Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis.

Authors:  Magdalena Sarah Volz; Verena Moos; Kristina Allers; Enno Luge; Anne Mayer-Scholl; Karsten Nöckler; Christoph Loddenkemper; Andreas Jansen; Thomas Schneider
Journal:  Clin Vaccine Immunol       Date:  2015-10-21

5.  Raised levels of Il-6, Il-17a, and Il-22 in fatal leptospirosis.

Authors:  Wan Shahriman Yushdie Wan Yusoff; Maha Abdullah; Zamberi Sekawi; Fairuz Amran; Muhammad Yazli Yuhana; Niazlin Mohd Taib; Ivan Kok Seng Yap; Leslie Thian Lung Than; Anim Md Shah; Alex van Belkum; Syafinaz Amin Nordin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-16       Impact factor: 3.267

Review 6.  Leptospirosis Pathophysiology: Into the Storm of Cytokines.

Authors:  Julie Cagliero; Sharon Y A M Villanueva; Mariko Matsui
Journal:  Front Cell Infect Microbiol       Date:  2018-06-20       Impact factor: 5.293

7.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No. 164: A 46-year-old man with abdominal pain, dyspnea and rapidly progressing multiorgan failure.

Authors:  Elisabeth Fabian; Christoph Wenisch; Florian Eisner; Tina Muhr; Philipp K Bauer; Kurt Prein; Urša Maierhofer; Sigurd F Lax; Robert Krause; Gernot Zollner; Wolfgang Weihs; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2021-04-19       Impact factor: 1.704

8.  Clinical spectrum of endemic leptospirosis in relation to cytokine response.

Authors:  Niroshana J Dahanayaka; Suneth B Agampodi; Indika Seneviratna; Janith Warnasekara; Rukman Rajapakse; Kosala Ranathunga; Michael Matthias; Joseph M Vinetz
Journal:  PLoS One       Date:  2021-12-08       Impact factor: 3.240

9.  Can cytokines response play a role in the treatment of fatal leptospirosis?

Authors:  Ahmad Alikhani; Kimia Mahmoodi; Leyla Delavaryan; Ebrahim Salehifar; Ali Reza Rafiei; Mahmoud Sadeghi Zavare
Journal:  Caspian J Intern Med       Date:  2022

10.  Cytokine response in human leptospirosis with different clinical outcomes: a systematic review.

Authors:  Indika Senavirathna; Devarajan Rathish; Suneth Agampodi
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.